PubRank

J Vives

Author PubWeight™ 75.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse. Eur J Immunol 1974 4.87
2 A major role for the Ir-1 region of the mouse H-2 complex in the mixed leukocyte reaction. Transplant Proc 1973 1.97
3 AccII polymorphism of the p53 gene. Nucleic Acids Res 1990 1.80
4 Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay. Mol Immunol 1984 1.61
5 Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 1999 1.37
6 Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 1991 1.33
7 Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003 1.22
8 Immunologic unresponsiveness after gastric administration of human gamma-globulin: antigen requirements and cellular parameters. J Immunol 1980 1.20
9 Histocompatibility-2 system in wild mice. X. Frequencies of H-2 and Ia antigens in wild mice from Europe and Africa. J Immunol 1980 1.16
10 CD43 monoclonal antibodies recognize the large sialoglycoprotein of human leukocytes. Eur J Immunol 1987 1.12
11 A second signal for T cell mitogenesis provided by monoclonal antibodies CD45 (T200). Eur J Immunol 1987 1.04
12 Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol 1992 1.03
13 Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 1988 1.03
14 HLA antigens in Forestier's disease, ankylosing spondylitis, and polyarthrosis of the hands. J Rheumatol Suppl 1977 1.02
15 IL-4 inhibits IL-2 synthesis and IL-2-induced up-regulation of IL-2R alpha but not IL-2R beta chain in CD4+ human T cells. J Immunol 1991 0.99
16 Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996 0.95
17 CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 1998 0.95
18 Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens 1979 0.94
19 Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer 1994 0.94
20 CD27 induction on thymocytes. J Immunol 1990 0.93
21 Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand. Eur J Immunol 1999 0.92
22 The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome. Rheumatology (Oxford) 2002 0.92
23 Biochemical characterization of recombinant and circulating human Spalpha. Tissue Antigens 2004 0.91
24 CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59fyn and p56lck in Jurkat T cell line. J Exp Med 1994 0.89
25 New experimental criteria for optimization of solid-phase antigen concentration and stability in ELISA. J Immunol Methods 1986 0.88
26 Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody. Eur J Immunol 1991 0.88
27 Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes. J Immunol 1991 0.86
28 Novel MASP2 variants detected among North African and Sub-Saharan individuals. Tissue Antigens 2005 0.86
29 MspI polymorphism of the human p53 gene. Nucleic Acids Res 1990 0.85
30 Assessment of mycophenolic acid-induced immunosuppression: a new approach. Clin Chem 2000 0.85
31 Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD. Immunology 1985 0.84
32 Association of an activation inducible serine kinase activity with CD5. J Immunol 1993 0.84
33 Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling. J Immunol 2001 0.83
34 Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells. Immunology 1990 0.83
35 Identification of a natural soluble form of human CD5. Tissue Antigens 1999 0.83
36 HLA antigens and scleroderma. Arch Dermatol Res 1981 0.83
37 Circulating immune complexes in immune thrombocytopenic purpura (ITP) Br J Haematol 1982 0.83
38 Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinases. Eur J Immunol 2001 0.83
39 Genomic characterization of CD84 reveals the existence of five isoforms differing in their cytoplasmic domains. Tissue Antigens 2000 0.83
40 Heterogeneity in the electrophoretic mobility of CD5 molecules after phorbol ester stimulation. Mol Immunol 1989 0.82
41 Conformation of the hypervariable region L3 without the key proline residue. Protein Sci 1996 0.82
42 An arthroscopic approach for the treatment of osteochondral focal defects with cell-free and cell-loaded PLGA scaffolds in sheep. Cytotechnology 2013 0.81
43 Genomic organization of the human CD5 gene. Immunogenetics 2000 0.81
44 Affinity maturation in the arsonate system: lack of dominance of high-affinity antibody subpopulations. Immunology 1986 0.81
45 Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J Immunol 1999 0.81
46 Lymphocytotoxic antibodies in primary biliary cirrhosis. Dig Dis Sci 1985 0.81
47 Expression of intercellular adhesion molecule-3 (ICAM-3/CD50) in malignant lymphoproliferative disorders and solid tumors. Tissue Antigens 1996 0.81
48 Viral particles in hybridoma clones secreting monoclonal antibodies. Lancet 1982 0.80
49 Serum levels of secretory IgA in ankylosing spondylitis. Scand J Rheumatol 1991 0.80
50 Transitory improvement of articular cartilage characteristics after implantation of polylactide:polyglycolic acid (PLGA) scaffolds seeded with autologous mesenchymal stromal cells in a sheep model of critical-sized chondral defect. Biotechnol Lett 2014 0.80
51 Association of the cell cycle regulatory proteins p45(SKP2) and CksHs1. Functional effect on CDK2 complex formation and kinase activity. J Biol Chem 2001 0.79
52 CDw50 and ICAM-3: two names for the same molecule. Eur J Immunol 1993 0.79
53 Prolymphocytic leukaemia of T-cell type: immunological, enzymatic and ultrastructural morphometric characteristics. Br J Haematol 1978 0.79
54 BglII and EcoRI polymorphism of the human nm23-H1 gene (NME1). Nucleic Acids Res 1991 0.79
55 Contributions of p53 and PMA to gamma-irradiation induced apoptosis in Jurkat cells. Hematol Cell Ther 1999 0.79
56 Involvement of the CDw50 molecule in allorecognition. Tissue Antigens 1990 0.79
57 Identification of a novel single-nucleotide polymorphism (Val554Ile) and definition of eight common alleles for human IL4RA exon 11. Tissue Antigens 2001 0.78
58 Specific immune response to Phleum pratense plant profilin in atopic patients and control subjects. Allergol Immunopathol (Madr) 2001 0.78
59 Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1). Leuk Res 1993 0.78
60 Signaling through CD50 (ICAM-3) stimulates T lymphocyte binding to human umbilical vein endothelial cells and extracellular matrix proteins via an increase in beta 1 and beta 2 integrin function. Eur J Immunol 1994 0.78
61 Phosphorylation-mediated changes in the electrophoretic mobility of CD5 molecules. Eur J Biochem 1990 0.78
62 Differential effects of anti-CD45 monoclonal antibody on human B cell proliferation: a monoclonal antibody recognizing a neuraminidase-sensitive epitope of the T200 molecule enhances anti-immunoglobulin-induced proliferation. Eur J Immunol 1990 0.77
63 Specific immune response to Parietaria judaica plant profilin: a low T cell proliferative response supports high IgE and skin prick test. Allergol Immunopathol (Madr) 2002 0.77
64 Abortion may sensitize the mother to HLA antigens. Tissue Antigens 1981 0.77
65 Effect of protein kinase C activators on the phosphorylation and the surface expression of the CDw50 leukocyte antigen. Eur J Biochem 1992 0.77
66 Biallelic Bgl II DNA polymorphism of the human p53 oncogene. Nucleic Acids Res 1990 0.77
67 CD148, a membrane protein tyrosine phosphatase, is able to induce tyrosine phosphorylation on human lymphocytes. Immunol Lett 1997 0.77
68 Identification of a new HLA-DRB1 allele (DRB1*0318) in three members of a Caucasian Spanish family. Tissue Antigens 2001 0.77
69 Evolutionarily conserved transcription regulatory elements within the 5'-flanking region of the human CD5 gene. Tissue Antigens 1996 0.77
70 Macroscopic and microscopic ionization constants of the thiol and amine groups in 1-methyl-4-mercaptopiperidine. Talanta 1983 0.77
71 HLA antibodies and period of gestation: decline in frequency of positive sera during last trimester. Tissue Antigens 1976 0.76
72 Stimulation through CD50 (ICAM-3) induces both activation and programmed cell death of human thymocytes. Tissue Antigens 1996 0.76
73 Biochemical and serological characterization of a public antigenic determinant present on HLA-B molecules. Tissue Antigens 1990 0.76
74 An antiplatelet monoclonal antibody that inhibits ADP and epinephrine-induced aggregation. Thromb Haemost 1984 0.76
75 CD50 (intercellular adhesion molecule-3) is expressed at higher levels on memory than on naive human T cells but induces a similar calcium mobilization on both subsets. Tissue Antigens 1995 0.76
76 Relevance of individual CD5 extracellular domains on antibody recognition, glycosylation and co-mitogenic signalling. Tissue Antigens 1999 0.76
77 Adsorption-desorption of antigen to polystyrene plates used in ELISA. Ann Inst Pasteur Immunol 1986 0.76
78 Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens. Clin Exp Immunol 1989 0.76
79 Identification of the amino acid residues defining an intralocus determinant in the alpha 1 domain of HLA-A molecules. Immunogenetics 1989 0.76
80 Further evidence against preeclampsia as an immune complex disease. Obstet Gynecol 1981 0.76
81 Interaction of DNA with lysine-rich polypeptides and proteins. The influence of polypeptide composition and secondary structure. J Mol Biol 1985 0.75
82 Discrepancies between serology- and sequence-based typing of HLA class I alleles among unrelated donor/recipient pairs. Transplant Proc 1999 0.75
83 Crystal structure of a helical oligopeptide model of polyglycine II and of other polyamides: acetyl-(glycyl-beta-alanyl)2-NH propyl. Biopolymers 1992 0.75
84 Characterization of a new HLA-C allele: Cw*1606. Tissue Antigens 2003 0.75
85 [Effect of methionine sulfone on the growth of Citrobacter intermedius C3 (author's transl)]. Rev Esp Fisiol 1977 0.75
86 Conservation of a polymorphic microsatellite at orthologous positions in the human and mouse CD5 gene promoter. Immunogenetics 1997 0.75
87 Description of a novel HLA-DRB1 allele found in a candidate for bone marrow transplantation. Tissue Antigens 2004 0.75
88 [Association of HLA-DR3 antigen to diseases with immunological components (author's transl)]. Sangre (Barc) 1980 0.75
89 HLA-B*5130, a new HLA-B allele carrying a rare nucleotide substitution in exon 4. Tissue Antigens 2003 0.75
90 Kinetics of IgM and IgG responses in neonatally thymectomized Swiss mice under persistent immunization with sheep red blood cells. Rev Esp Fisiol 1980 0.75
91 Different mechanisms regulate the monoclonal antibody-induced modulation of CD2, CD3, and CD5 in human lymphocytes. Cell Immunol 1993 0.75
92 Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen. Clin Immunol Immunopathol 1994 0.75
93 [Lymphocytotoxic antibodies in systemic lupus erythematosus: characteristics and relation to the clinicobiological activity of the disease]. Med Clin (Barc) 1986 0.75
94 Inhibitory effect of IL-4 on the sepharose-CD3-induced proliferation of the CD4CD45RO human T cell subset. Int Immunol 1990 0.75
95 [Autoimmune hemolytic anemia treated with heparin. Therapeutic note]. Sangre (Barc) 1972 0.75
96 Weight gain during pregnancy in adolescents: evaluation of a non-nutritional intervention. Rev Invest Clin 1994 0.75
97 [Measurement of chemolithothrotrophic denitrifying and sulphate reducing bacteria in an experimental field]. Microbiol Esp 1976 0.75
98 [Congenital absence of the inferior vena cava as a risk factor for pulmonar thromboembolism]. An Med Interna 2003 0.75
99 [HL-A system. I. Procurement of immune serums from pregnant women]. Sangre (Barc) 1971 0.75
100 [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)]. Med Clin (Barc) 1981 0.75
101 [Exopolysaccharides production in Pseudomonas and Achromobacter strains]. Microbiol Esp 1980 0.75
102 Solid-state conformation of some basic sequential polypeptides. Biopolymers 1985 0.75
103 [Determination of HL-A haplotypes and evolution of renal transplantation]. Rev Clin Esp 1975 0.75
104 Sequential evaluation of general immunocompetence in gynecologic cancer. Gynecol Oncol 1983 0.75
105 [Study of anti-DR antibodies in sterility and infertility (author's transl)]. Reproduccion 1981 0.75
106 Porcine epitopes recognized by mouse anti-human monoclonal antibodies. Transplant Proc 1995 0.75
107 T-lymphocyte subpopulations in Spanish haemophiliacs treated with commercial clotting factor concentrates. Antibiot Chemother (1971) 1983 0.75
108 Application of ELISA-inhibition to Aspergillus antigen standardization for immunodiagnosis. Sabouraudia 1985 0.75
109 Effects of HLA antibodies on pregnancy. Obstet Gynecol 1981 0.75
110 [Genetic recombination within the HLA system (author's transl)]. Sangre (Barc) 1980 0.75
111 Nitric oxide production by pig endothelial cells in response to human-derived injury. Transplantation 1998 0.75
112 Platelet aggregation technique used in the preparation of lymphocyte suspensions. Tissue Antigens 1971 0.75
113 Changes in idiotypic predominance in the anti-arsonate response by priming with anti-idiotypic antibodies. Scand J Immunol 1988 0.75
114 [Genetic study of HLA system in the Basque population ]. Sangre (Barc) 1982 0.75
115 [HL-A system. II. Analysis of the specificity of antibodies of the HL-A system]. Sangre (Barc) 1971 0.75
116 Human T-cell response to L14 pig cell line transfected with human ligands CD80 and CD86. Transplant Proc 1999 0.75
117 [Identification and characterization of the chemoorganotrophic denitrifying bacteria in an experimental field]. Microbiol Esp 1976 0.75
118 Xenogeneic hybridoma cells contain and secrete virus particles. Lancet 1983 0.75
119 Monoclonal antibody against HLA-Aw32 + A25. Is HLA-Aw32 an allele with no unique antigenic determinant? Hum Immunol 1983 0.75
120 [Effect of blood transfusions on the evoluation of the renal transplant]. Rev Clin Esp 1980 0.75
121 Influence of HBV replication and delta agent superinfection on T cell subsets and killer (Leu 7+) in chronic hepatitis B virus infection. J Hepatol 1986 0.75
122 Hybridoma process: ultrastructural cytology of different stages. J Submicrosc Cytol 1987 0.75
123 Clinically benign adult T-cell chronic lymphocytosis with unusual phenotype. Lancet 1983 0.75
124 Inhibition of CD27 expression by cyclosporine A; role of IL-2. Transplant Proc 1992 0.75
125 The protein kinase C-independent human B cell proliferation induced via surface immunoglobulins is unaffected by CD45 monoclonal antibodies. Immunobiology 1991 0.75
126 Dithiothreitol sensitivity versus autoreactivity in sera from hypersensitized patients. Transplant Proc 1992 0.75
127 [Unfavourable effects of platelet transfusions (author's transl)]. Sangre (Barc) 1980 0.75
128 [Effects of late overstimulation in children with early maternal deprivation]. Acta Psiquiatr Psicol Am Lat 1978 0.75
129 Identification of a novel HLA-Cw*07 variant (Cw*0714) in a German Caucasian family. Tissue Antigens 2000 0.75
130 Association of LLA-DR3 and herpes gestationis. Acta Derm Venereol 1981 0.75